Finance

Expert Consumers names Kikoff the top credit-building app of 2025 for its accessible pricing, no-interest plans, and consistent credit reporting for first-time users.

Expert Consumers names Kikoff the top credit-building app of 2025 for its accessible pricing, no-interest plans, and consistent credit reporting for first-time users.

DAYTONA BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE: BRO) announces it will release its 2025 second-quarter earnings on Monday, July 28, 2025, after the close of the market. On Tuesday, July 29, 2025, J. Powell Brown, Brown & Brown’s president and chief executive officer, and R. Andrew Watts, Brown & Brown’s executive vice president and chief financial officer, will host an investor update conference call concerning Brown & Brown's second-quarter 2025 financial results. You are invited to listen to the call, which will be broadcast live on Brown & Brown's website at 8:00 a.m. EDT. Simply log on to www.bbrown.com and click on "Investor Relations" and then "Calendar of Events."

DALLAS, July 1, 2025 /PRNewswire/ -- The Highland Opportunities and Income Fund (NYSE: HFRO) ("HFRO" or the "Fund") today announced its regular monthly distribution...

PHOENIX, July 1, 2025 /PRNewswire/ -- Realty Executives International is pleased to announce that it is aligning its ownership structure across Arizona and re-establishing common...

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) --

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Sage Therapeutics, Inc. (NASDAQ: SAGE) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed transaction, current Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable (i) $0.50 the first commercial sale of the drug Zurzuvae in Japan to third-aprty consumers following regulatory approval on or before June 30, 2026; (ii) $1.00 when net sales of Zurzuvae reach or exceed $300 million in the U.S. on or before December 31, 2028; and (iii) $1.00 when net sales of Zurzuvae reach or exceed $375 million in the U.S. on or before December 31, 2030. Is it a fair deal?

WASHINGTON, July 1, 2025 /PRNewswire/ -- FinRegLab today released new empirical research demonstrating that adopting machine learning techniques and incorporating cash flow data into...

Trusted Gold Experts Provide Families with Secure, Diversified Investment Solutions for a Stronger Tomorrow

  Trusted Gold Experts Provide Families with Secure, Diversified Investment Solutions for a Stronger Tomorrow

FRANKLIN, Tenn., July 1, 2025 /PRNewswire/ -- Mitsubishi Motors North America, Inc. (MMNA) today reported second-quarter 2025 sales of 22,116, driving the brand's year-to-date...

Old National Bank has announced the appointment of Matt Keen as Chief Information Officer.

Seasoned executive brings high-growth, enterprise experience at scale to fuel customer-focused, international expansion LOS ANGELES, July 1, 2025 /PRNewswire/ -- AuditBoard, the leading AI-powered...

Houston, TX, July 01, 2025 (GLOBE NEWSWIRE) -- Access guaranteed installment loans for bad credit through Honest Loans—no credit check, flexible terms, and fast approvals from direct lenders in 2025. Get the emergency funds you need, securely and stress-free.

Danville, California-based team brings $1.1 billion in assets to Steward Partners NEW YORK, July 1, 2025 /PRNewswire/ -- Steward Partners, a full-service, employee-owned, independent financial...

XRP momentum is strong as the $5 price target comes into focus. PBK Miner’s new XRP mining contracts offer investors a unique opportunity for daily passive income and long-term asset growth.

XRP momentum is strong as the $5 price target comes into focus. PBK Miner’s new XRP mining contracts offer investors a unique opportunity for daily passive income and long-term asset growth.

Bermuda, July 01, 2025 (GLOBE NEWSWIRE) -- - Relm Insurance (‘Relm’), the leading insurer for emerging and innovative industries, today announced the appointment of Dr. Rayyan Zafar, PhD, MRSB, as a Senior Scientific Advisor to the firm. In this role, Dr. Zafar will inform Relm’s strategic expansion into the emerging field of Psychedelics and Alternative Therapeutics, leveraging his world-class expertise to deepen Relm’s understanding of novel treatments for addiction and mental health disorders.